What is Betta Pharmaceuticals Co Price-to-Operating-Cash-Flow?
As of today (2024-05-15), Betta Pharmaceuticals Co's share price is ¥41.08.
Betta Pharmaceuticals Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.41. Hence, Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow Ratio for today is 17.06.
The historical rank and industry rank for Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:300558'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 14.97 Med: 60.8 Max: 110.51
Current: 17.07
During the past 13 years, Betta Pharmaceuticals Co's highest Price-to-Operating-Cash-Flow Ratio was 110.51. The lowest was 14.97. And the median was 60.80.
Betta Pharmaceuticals Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥0.58.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.41.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Betta Pharmaceuticals Co was 143.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 11.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.40% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.30% per year.
During the past 13 years, Betta Pharmaceuticals Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.90% per year. The lowest was -18.70% per year. And the median was 9.15% per year.
Betta Pharmaceuticals Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Betta Pharmaceuticals Co Price-to-Operating-Cash-Flow Chart
|
Betta Pharmaceuticals Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
47.92 |
67.66 |
63.11 |
66.76 |
23.65 |
|
Betta Pharmaceuticals Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
59.29 |
37.58 |
37.07 |
23.65 |
16.99 |
Competitive Comparison of Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow falls into.
Betta Pharmaceuticals Co Price-to-Operating-Cash-Flow Calculation
Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 41.08 | / | 2.408 |
| = | 17.06 |
Betta Pharmaceuticals Co's Share Price of today is ¥41.08.
Betta Pharmaceuticals Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.41.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Betta Pharmaceuticals Co (SZSE:300558) Business Description
Traded in Other Exchanges
N/A
Address
No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN
Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.
Betta Pharmaceuticals Co (SZSE:300558) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300558 has been successfully added to your